Xometry heads into the post-earnings stretch with the stock up 10% on the week, a wave of analyst upgrades hitting the tape, and short sellers quietly retreating — a setup that leaves bulls firmly in control.
The most striking story this week is the analyst response to Wednesday's results. Targets moved sharply higher across the board. Citigroup's Ronald Josey lifted his target to $110 from $98, maintaining Buy. Goldman Sachs raised to $104 from $78 while holding Neutral. Cantor Fitzgerald bumped to $110 from $85 on an existing Overweight. RBC moved to $100 from $85, staying at Sector Perform. The direction of travel is unanimous — even the cautious names are marking up significantly. The consensus mean target now runs at $109, modestly above the current $91.66 close, while Wedbush (assuming coverage in mid-July at Outperform) carries the highest published target at $126. Broadly, the Street is bullish on Xometry's AI-enabled manufacturing marketplace and its Siemens partnership, with the bull case centring on accelerating demand across aerospace, defence, and healthcare. Bears focus on U.S. revenue concentration and the durability of the low-cost customer acquisition model, along with macro sensitivity from geopolitical risk and any industrial slowdown.
The positioning picture reinforces the post-earnings constructive tone, though without any panic in the borrow market. Short interest eased roughly 12% over the past month to 6.1% of free float — still meaningful, but the trend is clearly lower since a peak around late July. Borrow costs have drifted down too, now running at 0.40% versus 0.56% a month ago, a low level that signals no friction for shorts wanting to exit. Availability is relaxed at nearly 295% of short interest, far from tight, with shares available to borrow nearly three times current short demand. Options traders meanwhile remain heavily skewed toward calls: the put/call ratio sits at 0.11, only slightly above its 20-day mean of 0.10 and a z-score of just over 1 — well within normal range and consistent with a market that is buying into the rally rather than hedging against it. The overall lending and options picture says shorts are not under pressure, but they are steadily reducing exposure into a rising stock.
Factor scores offer a nuanced overlay. EPS momentum is exceptional — ranking in the 92nd and 93rd percentiles on both 30-day and 90-day windows — and analyst recommendation momentum ranks in the 93rd percentile, consistent with the barrage of target raises following the print. The short score rank sits at just 18 out of 100, reflecting a relatively low short-pressure environment despite 6% float short. The valuation is not cheap: a P/E running near 78x and EV/EBITDA of around 59x, both down modestly over the past month as earnings growth has started to close the gap, but still elevated enough that execution risk remains priced in. The EPS surprise factor score of just 4 is the outlier — historically the company has not consistently beaten estimates, which keeps some skeptics cautious even after a positive quarter.
Institutional holders are broadly stable, with no dramatic reshuffling evident in recent filings. PRIMECAP remains the largest outside holder at 11.5% of shares. Fidelity added meaningfully in the quarter to June, building to 5.6%. Insider activity, while recent, was modest in scale — the CFO, CTO, and executive chairman all sold small tranches in early July around $91–$97, all carrying a significance score of just 1 out of 10, consistent with routine plan-based selling rather than a signal of changed conviction.
The stock's last earnings reaction on record — from the June print — was a gain of 2.1% on the day and 5.4% over five sessions, a muted but positive template. This quarter's 10% weekly move already exceeds that pattern. What to watch next is whether the Street's remaining neutral-to-cautious voices — Goldman and RBC both raised targets but held non-buy ratings — follow Wedbush's more constructive lead as earnings details circulate, and whether short interest continues its month-long decline or stabilises near current levels as the post-earnings dust settles.
See the live data behind this article on ORTEX.
Open XMTR on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
